• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jmedgeneJournal of Medical GeneticsCurrent TOCInstructions for authors
J Med Genet. Dec 2005; 42(12): 922–931.
Published online May 13, 2005. doi:  10.1136/jmg.2005.033597
PMCID: PMC1735959

Nine unknown rearrangements in 16p13.3 and 11p15.4 causing α- and ß-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification

Abstract

Background: Approximately 80% of the α- and 10% of the ß-thalassaemias are caused by genomic deletions involving the α- and ß-globin gene clusters on chromosomes 16p13.3 and 11p15.5, respectively. Gap-PCR, Southern blot analysis, and fluorescent in situ hybridisation are commonly used to identify these deletions; however, many deletions go undetected using conventional techniques.

Methods: Patient samples for which no abnormalities had been found using conventional DNA techniques were analysed by a three colour multiplex ligation-dependent probe amplification assay. Two sets of 35 and 50 probes, covering a region of 700 kb of the α- and 500 kb of the ß-globin gene cluster, respectively, were designed to detect rearrangements in the α- and ß-globin gene clusters.

Results: In 19 out of 38 patient samples, we found 11 different α-thalassaemia deletions, six of which were not previously described. Two novel deletions leaving the α-globin gene cluster intact were found to cause a complete downregulation of the downstream α-genes. Similarly, 31 out of 51 patient samples were found to carry 10 different deletions involving the ß-globin gene cluster, three of which were not previously described. One involves the deletion of the locus control region leaving the ß-globin gene cluster intact.

Conclusions: These deletions, which are not easily detected by conventional techniques, may have clinical implications during pregnancy ranging from mild to life threatening microcytic haemolytic anaemia in neonates. The approach as described here is a rapid and sensitive method for high resolution analysis of the globin gene clusters and for any region of the genome.

Full Text

The Full Text of this article is available as a PDF (476K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Thein SL. Beta-thalassaemia. Baillieres Clin Haematol. 1998 Mar;11(1):91–126. [PubMed]
  • Bernini LF, Harteveld CL. Alpha-thalassaemia. Baillieres Clin Haematol. 1998 Mar;11(1):53–90. [PubMed]
  • Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000 Feb;108(2):295–299. [PubMed]
  • Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood. 2000 Jan 1;95(1):360–362. [PubMed]
  • Craig JE, Barnetson RA, Prior J, Raven JL, Thein SL. Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood. 1994 Mar 15;83(6):1673–1682. [PubMed]
  • Knight SJ, Horsley SW, Regan R, Lawrie NM, Maher EJ, Cardy DL, Flint J, Kearney L. Development and clinical application of an innovative fluorescence in situ hybridization technique which detects submicroscopic rearrangements involving telomeres. Eur J Hum Genet. 1997 Jan-Feb;5(1):1–8. [PubMed]
  • Horsley SW, Daniels RJ, Anguita E, Raynham HA, Peden JF, Villegas A, Vickers MA, Green S, Waye JS, Chui DH, et al. Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects. Eur J Hum Genet. 2001 Mar;9(3):217–225. [PubMed]
  • Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat. 2003 Dec;22(6):428–433. [PubMed]
  • Sellner Loryn N, Taylor Graham R. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat. 2004 May;23(5):413–419. [PubMed]
  • Rooms Liesbeth, Reyniers Edwin, van Luijk Rob, Scheers Stefaan, Wauters Jan, Ceulemans Berten, Van Den Ende Jenneke, Van Bever Yolande, Kooy R Frank. Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation-dependent probe amplification (MLPA). Hum Mutat. 2004 Jan;23(1):17–21. [PubMed]
  • White Stefan J, Vink Geraldine R, Kriek Marjolein, Wuyts Wim, Schouten Jan, Bakker Bert, Breuning Martijn H, den Dunnen Johan T. Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat. 2004 Jul;24(1):86–92. [PubMed]
  • Giordano PC, Harteveld CL, Heister AJ, Batelaan D, van Delft P, Plug R, Losekoot M, Bernini LF. The molecular spectrum of beta-thalassemia and abnormal hemoglobins in the allochthonous and autochthonous dutch population. Community Genet. 1998;1(4):243–251. [PubMed]
  • Lin CK, Gau JP, Hsu HC, Jiang ML. Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions. Clin Lab Haematol. 1990;12(4):409–415. [PubMed]
  • Harteveld KL, Losekoot M, Fodde R, Giordano PC, Bernini LF. The involvement of Alu repeats in recombination events at the alpha-globin gene cluster: characterization of two alphazero-thalassaemia deletion breakpoints. Hum Genet. 1997 Apr;99(4):528–534. [PubMed]
  • Harteveld Cornelis L, van Delft Peter, Wijermans Pierre W, Kappers-Klunne Mies C, Weegenaar Jitske, Losekoot Monique, Giordano Piero C. A novel 7.9 kb deletion causing alpha+-thalassaemia in two independent families of Indian origin. Br J Haematol. 2003 Jan;120(2):364–366. [PubMed]
  • Harteveld Cornelis L, Osborne Cameron S, Peters Marjolein, van der Werf Steffie, Plug Rob, Fraser Peter, Giordano Piero C. Novel 112 kb (epsilonGgammaAgamma) deltabeta-thalassaemia deletion in a Dutch family. Br J Haematol. 2003 Sep;122(5):855–858. [PubMed]
  • Losekoot M, Fodde R, Gerritsen EJ, van de Kuit I, Schreuder A, Giordano PC, Vossen JM, Bernini LF. Interaction of two different disorders in the beta-globin gene cluster associated with an increased hemoglobin F production: a novel deletion type of (G) gamma + ((A) gamma delta beta)(0)-thalassemia and a delta(0)-hereditary persistence of fetal hemoglobin determinant. Blood. 1991 Feb 15;77(4):861–867. [PubMed]
  • Dimovski AJ, Divoky V, Adekile AD, Baysal E, Wilson JB, Prior JF, Raven JL, Huisman TH. A novel deletion of approximately 27 kb including the beta-globin gene and the locus control region 3'HS-1 regulatory sequence: beta zero-thalassemia or hereditary persistence of fetal hemoglobin? Blood. 1994 Feb 1;83(3):822–827. [PubMed]
  • Gilman JG. The 12.6 kilobase DNA deletion in Dutch beta zero-thalassaemia. Br J Haematol. 1987 Nov;67(3):369–372. [PubMed]
  • Orkin SH, Old JM, Weatherall DJ, Nathan DG. Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. Proc Natl Acad Sci U S A. 1979 May;76(5):2400–2404. [PMC free article] [PubMed]
  • White Stefan, Kalf Margot, Liu Qiang, Villerius Michel, Engelsma Dieuwke, Kriek Marjolein, Vollebregt Ellen, Bakker Bert, van Ommen Gert-Jan B, Breuning Martijn H, et al. Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet. 2002 Aug;71(2):365–374. [PMC free article] [PubMed]
  • Kent W James. BLAT--the BLAST-like alignment tool. Genome Res. 2002 Apr;12(4):656–664. [PMC free article] [PubMed]
  • Wilkie AO, Buckle VJ, Harris PC, Lamb J, Barton NJ, Reeders ST, Lindenbaum RH, Nicholls RD, Barrow M, Bethlenfalvay NC, et al. Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. I. Cases due to deletions involving chromosome band 16p13.3. Am J Hum Genet. 1990 Jun;46(6):1112–1126. [PMC free article] [PubMed]
  • Daniels RJ, Peden JF, Lloyd C, Horsley SW, Clark K, Tufarelli C, Kearney L, Buckle VJ, Doggett NA, Flint J, et al. Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum Mol Genet. 2001 Feb 15;10(4):339–352. [PubMed]
  • Harteveld KL, Losekoot M, Heister AJ, van der Wielen M, Giordano PC, Bernini LF. alpha-Thalassemia in The Netherlands: a heterogeneous spectrum of both deletions and point mutations. Hum Genet. 1997 Sep;100(3-4):465–471. [PubMed]
  • Abels J, Michiels JJ, Giordano PC, Bernini LF, Baysal E, Smetanina NS, Kazanetz EG, Leonova JY, Huisman TH. A de novo deletion causing epsilon gamma delta beta-thalassemia in a Dutch patient. Acta Haematol. 1996;96(2):108–109. [PubMed]
  • Henthorn PS, Smithies O, Mager DL. Molecular analysis of deletions in the human beta-globin gene cluster: deletion junctions and locations of breakpoints. Genomics. 1990 Feb;6(2):226–237. [PubMed]
  • Craig JE, Barnetson R, Weatherall DJ, Thein SL. Rapid detection of a 13.4-kb deletion causing delta beta thalassemia in an Egyptian family by polymerase chain reaction. Blood. 1993 Feb 1;81(3):861–863. [PubMed]
  • Mishima N, Landman H, Huisman TH, Gilman JG. The DNA deletion in an Indian delta beta-thalassaemia begins one kilobase from the A gamma globin gene and ends in an L1 repetitive sequence. Br J Haematol. 1989 Nov;73(3):375–379. [PubMed]
  • Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics. 2005 Feb;6(1):29–35. [PubMed]
  • Harteveld Cornelis L, Muglia Maria, Passarino Giuseppe, Kielman Menno F, Bernini Luigi F. Genetic polymorphism of the major regulatory element HS-40 upstream of the human alpha-globin gene cluster. Br J Haematol. 2002 Dec;119(3):848–854. [PubMed]
  • Higgs DR, Sharpe JA, Wood WG. Understanding alpha globin gene expression: a step towards effective gene therapy. Semin Hematol. 1998 Apr;35(2):93–104. [PubMed]
  • Anguita Eduardo, Sharpe Jacqueline A, Sloane-Stanley Jacqueline A, Tufarelli Cristina, Higgs Douglas R, Wood William G. Deletion of the mouse alpha-globin regulatory element (HS -26) has an unexpectedly mild phenotype. Blood. 2002 Nov 15;100(10):3450–3456. [PubMed]
  • Locke DP, Segraves R, Nicholls RD, Schwartz S, Pinkel D, Albertson DG, Eichler EE. BAC microarray analysis of 15q11-q13 rearrangements and the impact of segmental duplications. J Med Genet. 2004 Mar;41(3):175–182. [PMC free article] [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...